← Open Payments lookup

ROSEMARY BUFALO: Open Payments

NPI 1770281230 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$318 in 15 payments from 10 companies in 2025. Trend: 2023 $384 · 2024 $1,761 · 2025 $318

Food & beverage: $318
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.3$69
Amgen Inc.3$66
Novo Nordisk Inc2$40
Ardelyx, Inc.1$25
AstraZeneca Pharmaceuticals LP1$23
Merck Sharp & Dohme LLC1$23
Novartis Pharmaceuticals Corporation1$22
Exact Sciences Corporation1$21
Lilly USA, LLC1$16
Boehringer Ingelheim Pharmaceuticals, Inc.1$15

Products named: FANAPT, Repatha, JARDIANCE, IBSRELA, FARXIGA, GARDASIL 9, ENTRESTO, The Cologuard Plus Collection Kit.

Industry payments across MA — which companies pay providers there.